Diagnosis, Clinical Features, and Management of Patients With Granulomatous Cheilitis JAMA Dermatology
TAKE-HOME MESSAGE
Nine patients with granulomatous cheilitis (GC) were identified using the electronic medical records at the University of Pennsylvania to describe the clinical features and treatment response in patients with GC. The average age of patients with GC was 46.6 years, a majority were women (7/9), and painless upper-lip edema was their chief complaint. Six of the 9 patients underwent serial intralesional triamcinolone injections, which led to partial response in 3 and complete response in 2; however, recurrence was common. Other treatment strategies included adalimumab, cetirizine, doxycycline, hydroxychloroquine, prednisone, topical clobetasol, and debulking surgery, with only 1 patient treated with prednisone and 1 patient with no treatment achieving complete response. The differential diagnosis for GC should include sarcoidosis, Crohn's disease, and allergic contact dermatitis.
- GC is a rare subtype of orofacial granulomatosis with a chronic course that is generally difficult to treat. This is one of very few case-series with more than 5 patients published to date and reiterates that treatment for GC patients is a challenge. Patients should be counseled that the course is chronic, partial response to treatment and exacerbations are common, and long-term treatment may be indicated.
Diagnosis, Clinical Features, and Management of Patients With Granulomatous Cheilitis
JAMA Dermatol 2020 Nov 11;[EPub Ahead of Print], JS Durgin, O Rodriguez, T Sollecito, T Tanaka, JC English, BE Shields, M RosenbachSkin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home